cache/f3921394aa0a7368e9d061ac8dbc4b1847129381f16ae18f9be3c8c2cee5f6cc

COM:FOSUNPHARMA

Fosun Pharma

  • Stock

Last Close

26.24

25/11 03:29

Market Cap

53.38B

Beta: -

Volume Today

6.41M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.44B
-
1.61B
11.47%
1.63B
1.07%
1.66B
2.03%
2.21B
33.19%
3.02B
36.57%
3.61B
19.71%
4.55B
25.95%
5.32B
16.83%
6.18B
16.17%
7.21B
16.72%
average payables
1.02B
-
1.02B
0.06%
976.81M
4.30%
1.10B
12.51%
1.47B
33.36%
2.06B
40.39%
2.37B
14.96%
2.84B
20.20%
4.18B
46.89%
5.67B
35.86%
5.90B
3.91%
average receivables
2.08B
-
2.79B
33.93%
2.92B
4.70%
2.75B
5.86%
3.75B
36.46%
4.89B
30.39%
5.56B
13.82%
6.57B
17.98%
8.39B
27.76%
10.16B
21.11%
10.25B
0.88%
book value per share
6.88
-
7.26
5.55%
7.91
8.91%
9.57
21.01%
10.29
7.58%
11.06
7.39%
12.48
12.89%
14.44
15.73%
15.33
6.16%
17.09
11.45%
17.11
0.14%
capex per share
-0.47
-
-0.49
4.46%
-0.54
10.25%
-0.83
54.23%
-0.88
6.45%
-1.25
42.19%
-1.55
23.60%
-1.73
11.71%
-1.95
12.30%
-2.26
16.03%
-2.00
11.44%
capex to depreciation
-2.50
-
-2.00
19.91%
-1.90
5.09%
-2.62
37.82%
-2.31
11.81%
-2.41
4.00%
-2.69
11.91%
-2.66
1.06%
-2.71
1.79%
-2.52
7.00%
-1.71
32.12%
capex to operating cash flow
-1.03
-
-0.93
9.28%
-0.76
18.28%
-0.91
19.51%
-0.84
7.64%
-1.08
27.93%
-1.23
14.25%
-1.72
39.89%
-1.26
26.78%
-1.40
10.88%
-1.22
12.40%
capex to revenue
-0.10
-
-0.09
10.53%
-0.10
5.27%
-0.13
34.08%
-0.12
10.86%
-0.13
8.79%
-0.14
8.78%
-0.15
5.63%
-0.13
12.92%
-0.13
5.10%
-0.13
3.16%
cash per share
1.40
-
1.62
16.33%
1.77
8.81%
2.61
47.53%
3.04
16.45%
3.62
19.27%
3.91
7.99%
4.66
19.14%
5.69
22.19%
6.58
15.62%
5.84
11.31%
days of inventory on hand
106.29
-
87.17
17.99%
95.40
9.44%
90.77
4.86%
131.94
45.36%
115.76
12.26%
124.60
7.63%
140.30
12.60%
98.74
29.62%
108.42
9.80%
118.99
9.75%
days payables outstanding
74.83
-
49.16
34.30%
60.68
23.42%
62.44
2.91%
85.48
36.88%
82.16
3.88%
75.80
7.74%
89.38
17.91%
91.37
2.22%
98.99
8.35%
86.94
12.18%
days sales outstanding
82.39
-
100.73
22.26%
72.91
27.62%
74.28
1.87%
89.07
19.91%
76.99
13.56%
75.00
2.58%
87.40
16.53%
89.06
1.91%
89.67
0.68%
86.06
4.03%
debt to assets
0.19
-
0.22
15.80%
0.29
29.21%
0.26
10.19%
0.33
27.72%
0.33
0.45%
0.29
12.50%
0.29
0.29%
0.26
9.44%
0.28
8.61%
0.30
4.64%
debt to equity
0.37
-
0.47
27.65%
0.60
28.11%
0.51
15.69%
0.80
58.45%
0.83
3.52%
0.69
17.17%
0.65
5.52%
0.62
4.70%
0.68
9.67%
0.74
8.66%
dividend yield
0.02
-
0.02
7.83%
0.02
3.39%
0.02
8.29%
0.01
40.11%
0.03
144.39%
0.03
15.74%
0.01
51.64%
0.02
15.33%
0.03
68.79%
0.02
34.57%
earnings yield
0.05
-
0.04
6.08%
0.05
4.47%
0.05
14.79%
0.03
44.47%
0.05
71.01%
0.05
1.57%
0.03
45.80%
0.04
42.92%
0.04
7.20%
0.04
11.39%
enterprise value
46.22B
-
52.57B
13.73%
60.88B
15.82%
58.88B
3.29%
120.65B
104.90%
69.20B
42.65%
80.34B
16.10%
152.34B
89.62%
139.03B
8.74%
105.95B
23.80%
92.34B
12.84%
enterprise value over ebitda
12.38
-
13.02
5.23%
13.33
2.36%
12.09
9.28%
21.71
79.49%
12.03
44.58%
10.19
15.30%
22.10
116.92%
14.95
32.36%
9.96
33.35%
23.30
133.85%
ev to operating cash flow
45.69
-
43.80
4.14%
37.56
14.25%
27.91
25.70%
46.76
67.56%
23.46
49.84%
24.93
6.29%
59.05
136.86%
35.21
40.38%
25.12
28.65%
21.16
15.75%
ev to sales
4.62
-
4.37
5.46%
4.83
10.46%
4.03
16.64%
6.51
61.73%
2.78
57.34%
2.81
1.21%
5.03
78.85%
3.56
29.09%
2.41
32.37%
2.25
6.86%
free cash flow per share
-0.01
-
0.04
375.84%
0.17
376.70%
0.08
51.63%
0.17
105.27%
-0.09
153.35%
-0.29
225.88%
-0.73
150.49%
-0.40
44.76%
-0.64
59.93%
-0.36
43.08%
free cash flow yield
-0.00
-
0.00
356.10%
0.01
328.20%
0.00
50.89%
0.00
8.60%
-0.00
208.29%
-0.01
164.02%
-0.01
23.41%
-0.01
39.06%
-0.02
122.10%
-0.01
19.31%
graham net net
-2.78
-
-4.01
44.22%
-4.68
16.63%
-4.06
13.31%
-8.13
100.38%
-8.78
7.99%
-8.04
8.36%
-6.93
13.86%
-8.02
15.73%
-9.33
16.38%
-11.29
21.03%
graham number
11.86
-
12.26
3.34%
13.80
12.55%
16.14
16.98%
17.15
6.26%
16.31
4.88%
19.11
17.11%
21.56
12.83%
25.28
17.27%
23.45
7.25%
18.55
20.88%
income quality
0.42
-
0.51
20.15%
0.56
11.50%
0.66
16.00%
0.72
9.87%
0.98
35.74%
0.86
11.88%
0.65
23.93%
0.79
20.92%
1.07
34.95%
1.83
71.21%
intangibles to total assets
0.19
-
0.17
8.40%
0.17
1.77%
0.16
5.06%
0.27
65.95%
0.26
5.30%
0.26
2.62%
0.24
8.15%
0.24
1.52%
0.25
0.13%
0.25
1.02%
interest coverage
8.04
-
5.77
28.28%
7.02
21.60%
6.96
0.73%
7.06
1.32%
3.80
46.10%
5.97
56.91%
5.36
10.19%
7.68
43.23%
8.61
12.14%
0.64
92.60%
interest debt per share
2.68
-
3.58
33.58%
4.95
38.20%
5.05
2.06%
8.48
68.00%
9.54
12.43%
8.99
5.69%
9.72
8.06%
9.81
0.90%
11.96
21.99%
13.11
9.60%
inventory turnover
3.43
-
4.19
21.93%
3.83
8.63%
4.02
5.10%
2.77
31.21%
3.15
13.98%
2.93
7.09%
2.60
11.19%
3.70
42.09%
3.37
8.93%
3.07
8.88%
invested capital
0.37
-
0.47
27.65%
0.60
28.11%
0.51
15.69%
0.80
58.45%
0.83
3.52%
0.69
17.17%
0.65
5.52%
0.62
4.70%
0.68
9.67%
0.74
8.66%
market cap
43.67B
-
48.46B
10.98%
54.01B
11.45%
53.66B
0.65%
107.61B
100.55%
54.54B
49.32%
67.97B
24.62%
138.29B
103.47%
125.09B
9.54%
91.94B
26.50%
66.37B
27.81%
net current asset value
-4.82B
-
-7.57B
56.90%
-9.21B
21.63%
-7.75B
15.79%
-17.17B
121.50%
-18.96B
10.39%
-16.51B
12.90%
-12.62B
23.59%
-14.49B
14.87%
-17.78B
22.65%
-22.98B
29.29%
net debt to ebitda
0.68
-
1.02
48.81%
1.51
47.82%
1.07
28.73%
2.35
118.68%
2.55
8.61%
1.57
38.43%
2.04
29.91%
1.50
26.50%
1.32
12.09%
6.55
397.51%
net income per share
0.91
-
0.92
1.16%
1.07
16.30%
1.21
13.08%
1.27
4.96%
1.07
15.75%
1.30
21.50%
1.43
10.00%
1.85
29.55%
1.43
22.81%
0.89
37.49%
operating cash flow per share
0.45
-
0.52
15.15%
0.71
34.91%
0.91
29.06%
1.05
15.26%
1.17
11.15%
1.26
8.19%
1.01
20.14%
1.54
53.39%
1.62
4.64%
1.63
1.10%
payables turnover
4.88
-
7.42
52.20%
6.02
18.98%
5.85
2.83%
4.27
26.95%
4.44
4.03%
4.82
8.39%
4.08
15.19%
3.99
2.18%
3.69
7.70%
4.20
13.86%
receivables turnover
4.43
-
3.62
18.21%
5.01
38.15%
4.91
1.83%
4.10
16.61%
4.74
15.69%
4.87
2.65%
4.18
14.19%
4.10
1.87%
4.07
0.68%
4.24
4.20%
research and ddevelopement to revenue
0.04
-
0.05
7.18%
0.05
13.26%
0.05
8.06%
0.06
13.36%
0.06
7.20%
0.07
20.27%
0.09
29.16%
0.10
6.58%
0.10
0.43%
0.09
7.23%
return on tangible assets
0.08
-
0.07
14.74%
0.08
7.30%
0.08
1.48%
0.07
9.79%
0.05
25.34%
0.06
14.72%
0.06
2.53%
0.07
16.53%
0.05
31.38%
0.03
39.69%
revenue per share
4.48
-
5.24
16.76%
5.48
4.73%
6.31
15.04%
7.53
19.41%
9.85
30.70%
11.19
13.62%
11.83
5.76%
15.26
28.97%
16.85
10.40%
15.41
8.55%
roe
0.13
-
0.13
4.16%
0.14
6.78%
0.13
6.55%
0.12
2.43%
0.10
21.54%
0.10
7.62%
0.10
4.95%
0.12
22.03%
0.08
30.74%
0.05
37.58%
roic
0.11
-
0.09
23.23%
0.10
13.18%
0.09
4.91%
0.08
14.08%
0.06
26.09%
0.10
67.94%
0.06
34.08%
0.08
25.81%
0.09
16.72%
0.01
92.80%
sales general and administrative to revenue
0.03
-
0.03
0.93%
0.03
4.59%
0.04
28.46%
0.03
25.17%
0.03
15.10%
0.03
8.55%
0.03
2.23%
0.02
30.41%
0.02
3.63%
0.03
27.07%
shareholders equity per share
6.88
-
7.26
5.55%
7.91
8.91%
9.57
21.01%
10.29
7.58%
11.06
7.39%
12.48
12.89%
14.44
15.73%
15.33
6.16%
17.09
11.45%
17.11
0.14%
stock based compensation to revenue
0.00
-
0.00
419.41%
0.00
31.45%
0.00
52.25%
0.00
9.54%
0.00
24.79%
0.00
29.59%
tangible asset value
12.05B
-
12.94B
7.36%
14.12B
9.16%
18.13B
28.37%
13.00B
28.27%
15.55B
19.57%
19.22B
23.65%
25.81B
34.25%
25.54B
1.03%
27.85B
9.02%
29.03B
4.23%
tangible book value per share
5.41
-
5.63
4.20%
6.14
9.03%
7.82
27.28%
5.29
32.39%
6.14
16.23%
7.52
22.48%
10.08
33.92%
9.99
0.82%
10.67
6.81%
10.87
1.86%
working capital
1.71B
-
-873.29M
151.12%
-2.61B
199.31%
655.75M
125.09%
-1.54B
335.45%
78.48M
105.08%
2.97B
3,683.86%
212.45M
92.85%
1.11B
424.68%
1.98B
77.73%
34.99M
98.23%

All numbers in (except ratios and percentages)